Jlroz 15 Orally Disintegrating Tablet
By Jlroz
Rx
10 Tablet MD in a Strip

Composition
Lansoprazole(15mg)

Manufacturer - Uvkan Healthcare Pvt Ltd
#15, 1st Floor, 10th Cross, 7th Main, Muthyal Nagar, Opp. Muthyalamma Temple, MES, Bangalore - 560064

Expires on or after
October, 2025

liver
Caution should be exercised when using Jlroz 15 Orally Disintegrating Tablet in individuals with severe liver disease. It may be necessary to adjust the dosage of Jlroz 15 Orally Disintegrating Tablet in such cases. Patients are advised to consult their healthcare provider for guidance on the appropriate use of the medication.

kidney
Jlroz 15 Orally Disintegrating Tablet is safe for patients with kidney disease. No dose adjustment is needed.

alcohol
When taking Jlroz 15 Orally Disintegrating Tablet, caution should be taken when consuming alcohol. It is recommended to consult your doctor regarding alcohol intake while using this medication.

driving
Jlroz 15 Orally Disintegrating Tablet can reduce alertness, impact vision, and cause drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
Jlroz 15 Orally Disintegrating Tablet is generally safe to use during pregnancy based on animal studies. Limited human studies show no significant adverse effects on the developing baby.

breastfeeding
During breastfeeding, Jlroz 15 Orally Disintegrating Tablet is considered safe to use based on limited human data indicating no significant risk to the baby.
Habit Forming | No |
Chemical Class | Timoprazole Derivative |
Therapeutic Class | GASTRO INTESTINAL |
Action Class | Proton pump inhibitors |
₹68
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024